Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Radnet ( (RDNT) ) just unveiled an announcement.
On January 7, 2026, RadNet expanded its executive leadership team, promoting Stephen Forthuber and Norman Hames from presidents and chief operating officers of Eastern and Western Operations, respectively, to presidents and chief executive officers of those regions, while elevating Mital Patel to executive vice president and chief operating officer and appointing Dr. Greg Sorensen, M.D., from chief science officer to chief strategy officer. In conjunction with these promotions and broader leadership realignments, RadNet’s compensation committee approved amendments to executive employment agreements to raise base salaries for several senior leaders, moves that underscore the company’s emphasis on seasoned internal talent to support its recent record financial performance and to strengthen its positioning in both its imaging center and digital health segments as it pursues further growth and a more proactive, prevention-oriented role in healthcare.
The most recent analyst rating on (RDNT) stock is a Buy with a $92.00 price target. To see the full list of analyst forecasts on Radnet stock, see the RDNT Stock Forecast page.
Spark’s Take on RDNT Stock
According to Spark, TipRanks’ AI Analyst, RDNT is a Neutral.
Radnet’s overall stock score is driven by strong earnings call results, showcasing record-breaking revenue and positive guidance. However, financial performance is hindered by profitability and leverage concerns, and technical indicators suggest potential short-term weakness. Valuation remains a challenge due to negative earnings.
To see Spark’s full report on RDNT stock, click here.
More about Radnet
RadNet, Inc. is a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States, operating a network of 407 owned and/or operated imaging centers across markets including Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. The company also develops and markets digital health, radiology information technology and artificial intelligence solutions under its DeepHealth brand, alongside teleradiology professional services and related products for customers in the diagnostic imaging industry, supported by a workforce of more than 11,000 team members.
Average Trading Volume: 859,235
Technical Sentiment Signal: Strong Buy
Current Market Cap: $5.98B
For an in-depth examination of RDNT stock, go to TipRanks’ Overview page.